نتایج جستجو برای: mf59

تعداد نتایج: 256  

Journal: :The Journal of infectious diseases 2011
Steffanie Sabbaj Robert F Pass Paul A Goepfert Sylvie Pichon

Traditionally, vaccines have been utilized to generate immune responses to a pathogen in a naive population. In the setting of congenital cytomegalovirus (CMV) infection, a vaccine that, when administered to women already infected with CMV, could boost the mother's immunity to CMV would most likely be beneficial in diminishing in utero transmission of CMV. However, the ability to boost an immun...

Journal: :The Journal of infectious diseases 2000
S Langermann R Möllby J E Burlein S R Palaszynski C G Auguste A DeFusco R Strouse M A Schenerman S J Hultgren J S Pinkner J Winberg L Guldevall M Söderhäll K Ishikawa S Normark S Koenig

Escherichia coli FimH adhesin mediates binding to the bladder mucosa. In mice, a FimH vaccine protects against bacterial challenge. In this study, 4 monkeys were inoculated with 100 microgram of FimCH adhesin-chaperone complex mixed with MF59 adjuvant, and 4 monkeys were given adjuvant only intramuscularly. After 2 doses (day 0 and week 4), a booster at 48 weeks elicited a strong IgG antibody r...

2013
Peter H. Goff Dirk Eggink Christopher W. Seibert Rong Hai Luis Martínez-Gil Florian Krammer Peter Palese

The global population remains vulnerable in the face of the next pandemic influenza virus outbreak, and reformulated vaccinations are administered annually to manage seasonal epidemics. Therefore, development of a new generation of vaccines is needed to generate broad and persistent immunity to influenza viruses. Here, we describe three adjuvants that enhance the induction of stalk-directed ant...

2005
Yu Rong Yang Tao Sun Zhengzhi Li Xiuping Li Rui Zhao Li Cheng Xiao Pan Philip S. Craig Dominique A. Vuitton Donald P. McManus

demonstrated enhanced entry into renal epithelial cells (10). In our studies, we did not find enhanced virus replication in the respiratory tract of vaccinated mice upon SARS-CoV challenge. However, since mice are a model of SARS-CoV infection but not disease, the issue of disease enhancement will have to be carefully evaluated if and when an appropriate animal model in which this phenomenon ca...

Journal: :The Journal of infectious diseases 2010
Ranjit Ray Keith Meyer Arup Banerjee Arnab Basu Stephen Coates Sergio Abrignani Michael Houghton Sharon E Frey Robert B Belshe

Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 were used with MF59 adjuvant as a candidate vaccine for a phase 1 safety and immunogenicity trial. Ten of 41 vaccinee serum samples displayed a neutralization titer of > or =1:20 against vesicular stomatitis virus (VSV)-HCV pseudotype, 15 of 36 serum samples tested had a neutralization titer of > or =1:400 against human immunodeficiency v...

Journal: :Deutsches Arzteblatt international 2013
Peter Wutzler Roland Hardt Markus Knuf Klaus Wahle

BACKGROUND The main target groups for influenza vaccination are the elderly, the chronically ill, infants, and toddlers. Influenza vaccines are needed that suit the immunological particularities of each of these age and risk groups. Recent years have seen the approval of influenza vaccines that are more immunogenic than before, but whose use in Germany is limited by the restriction of reimburse...

Journal: :Thorax 2011
Federico Alghisi Paolo Palma Enza Montemitro Stefania Bernardi Giuseppe Pontrelli Paolo Rossi Vincenzina Lucidi

Viral respiratory tract infections may determine lung function deterioration in patients affected by cystic fibrosis (CF). Viruses may have a synergistic action with bacteria to damage the respiratory tract; they may also promote airway bacterial colonisation. Influenza virus infection has been described to increase the number of CF pulmonary exacerbations and the incidence of hospitalisation. ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید